Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent infringement
Pharma
Ascendis pays 20% royalties in patent settlement with BioMarin
The two pharmas sidestepped significant legal overhang with a licensing deal that analysts are calling mutually beneficial.
Donavyn Coffey
Aug 31, 2026 1:56pm
Aurinia deal with Teva keeps Lupkynis generic in check until '36
Aug 20, 2026 11:28am
SK settles with MSN over generic of seizure med Xcopri: reports
Aug 19, 2026 11:21am
Bayer sues Moderna, J&J and Pfizer/BioNTech over COVID vax tech
Jan 7, 2026 8:35am
Merck's Keytruda SC launch in Germany faces legal hurdle
Dec 5, 2025 9:30am
AbbVie, BeOne end BTK inhibitor patent fight
Oct 2, 2025 10:29am
